
DAFNA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | SPRY | 141K | $1.41M |
![]() | APRE | 137K | $202.33K |
![]() | ALKS | 135K | $4.04M |
![]() | GLPG | 130K | $4.51M |
![]() | FHTX | 127K | $620.34K |
![]() | ADCT | 122K | $488.32K |
![]() | MDWD | 114K | $2.05M |
![]() | ORIC | 105K | $1.26M |
![]() | MBX | 85K | $1.49M |
![]() | MLYS | 83K | $3.17M |
![]() | KROS | 81K | $1.28M |
![]() | RAPP | 75K | $2.23M |
![]() | NBIX | 71K | $9.91M |
![]() | DXCM | 66K | $4.41M |
![]() | VKTX | 65K | $1.70M |
![]() | BCYC | 64K | $499.17K |
![]() | KRRO | 61K | $2.91M |
![]() | GPCR | 59K | $1.65M |
![]() | BWAY | 57K | $858.48K |
![]() | NKTR | 55K | $3.13M |

ARS Pharmaceuticals, Inc.
SPRY
Shares Held
141K
Value
$1.41M

Aprea Therapeutics, Inc.
APRE
Shares Held
137K
Value
$202.33K

Alkermes plc
ALKS
Shares Held
135K
Value
$4.04M

Galapagos N.V.
GLPG
Shares Held
130K
Value
$4.51M

Foghorn Therapeutics Inc.
FHTX
Shares Held
127K
Value
$620.34K

ADC Therapeutics S.A.
ADCT
Shares Held
122K
Value
$488.32K

MediWound Ltd.
MDWD
Shares Held
114K
Value
$2.05M

ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
105K
Value
$1.26M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
85K
Value
$1.49M

Mineralys Therapeutics, Inc.
MLYS
Shares Held
83K
Value
$3.17M

Keros Therapeutics, Inc.
KROS
Shares Held
81K
Value
$1.28M

Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
75K
Value
$2.23M

Neurocrine Biosciences, Inc.
NBIX
Shares Held
71K
Value
$9.91M

DexCom, Inc.
DXCM
Shares Held
66K
Value
$4.41M

Viking Therapeutics, Inc.
VKTX
Shares Held
65K
Value
$1.70M

Bicycle Therapeutics plc
BCYC
Shares Held
64K
Value
$499.17K

Korro Bio, Inc.
KRRO
Shares Held
61K
Value
$2.91M

Structure Therapeutics Inc.
GPCR
Shares Held
59K
Value
$1.65M

BrainsWay Ltd.
BWAY
Shares Held
57K
Value
$858.48K

Nektar Therapeutics
NKTR
Shares Held
55K
Value
$3.13M
